Uccelli Antonio, de Rosbo Nicole Kerlero
Department of Neurology, Rehabilitation, Ophthalmology, Genetics, and Maternal and Child Health (DINOGMI).
Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
Ann N Y Acad Sci. 2015 Sep;1351:114-26. doi: 10.1111/nyas.12815. Epub 2015 Jul 6.
Mesenchymal stem cells (MSCs) are being increasingly investigated as a therapeutic alternative, not only for their possible regenerative potential but also for their immunomodulatory action, which is being exploited for controlling diseases associated with inflammation. Understanding their direct and indirect target cells, as well as their mode of action and relevant pathways, is a prerequisite for the appropriate and optimal use of MSCs in therapy. Here, we review recent findings on the effects of MSCs on adaptive and innate immune cells. We also consider the impact of the environment on MSC profile, both anti- and proinflammatory, and the mechanisms and molecular pathways through which their effects are mediated, both at the MSC and target cell levels.
间充质干细胞(MSCs)作为一种治疗选择正受到越来越多的研究,这不仅是因为它们可能具有的再生潜力,还因为它们的免疫调节作用,这种作用正被用于控制与炎症相关的疾病。了解它们的直接和间接靶细胞,以及它们的作用方式和相关途径,是在治疗中适当和最佳使用间充质干细胞的先决条件。在这里,我们综述了关于间充质干细胞对适应性和先天性免疫细胞影响的最新研究结果。我们还考虑了环境对间充质干细胞抗炎和促炎特性的影响,以及在间充质干细胞和靶细胞水平上介导其作用的机制和分子途径。